Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Lion Biotechnologies (LBIO)

Lion Biotechnologies (LBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lion Biotechnologies 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 USA

www.lbio.com P: 650-260-7120

Description:

Lion Biotechnologies, Inc. is developing autologous cell therapies for the treatment of cancer. The Company's lead product candidate, C'ntego(TM), is an autologous cell therapy indicated for the treatment of metastatic melanoma. Lion Biotechnologies, Inc., formerly known as Genesis Biopharma, Inc., is based in Woodland Hills, California.

Key Statistics

Overview:

Market Capitalization, $K 433,332
Shares Outstanding, K 62,350
Annual Sales, $ 0 K
Annual Net Income, $ -52,890 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -20,680 K
60-Month Beta 4.18
% of Insider Shareholders 13.20%
% of Institutional Shareholders 77.97%

Growth:

1-Year Return -6.59%
3-Year Return 0.72%
5-Year Return -84.20%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 08/14/17
Earnings Per Share ttm -1.13
EPS Growth vs. Prev Qtr -32.00%
EPS Growth vs. Prev Year -135.71%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 09/27/13

LBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -10.07%
Return-on-Assets % -9.81%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.89
Book Value/Share 2.40
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar